Income Statement (TTM)
PT Ikapharmindo Putramas Tbk Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 12-31 |
2021 12-31 |
2022 12-31 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 715,801 | 380,917 | 398,735 | 441,137 | 429,886 | 424,360 | 424,889 | 412,069 | 405,031 | 392,289 |
| Change (%) | -46.78 | 4.68 | 10.63 | -2.55 | -1.29 | 0.12 | -3.02 | -1.71 | -3.15 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 453,102 | 203,645 | 217,946 | 252,169 | 242,951 | 238,623 | 233,555 | 226,541 | 228,007 | 220,050 |
| Change (%) | -55.06 | 7.02 | 15.70 | -3.66 | -1.78 | -2.12 | -3.00 | 0.65 | -3.49 | |
| % of Revenue | 63.30 | 53.46 | 54.66 | 57.16 | 56.52 | 56.23 | 54.97 | 54.98 | 56.29 | 56.09 |
| Gross Operating Profit | 262,700 | 177,272 | 180,788 | 188,968 | 186,936 | 185,737 | 191,334 | 185,528 | 177,024 | 172,240 |
| Change (%) | -32.52 | 1.98 | 4.52 | -1.08 | -0.64 | 3.01 | -3.03 | -4.58 | -2.70 | |
| % of Revenue | 36.70 | 46.54 | 45.34 | 42.84 | 43.48 | 43.77 | 45.03 | 45.02 | 43.71 | 43.91 |
| SG&A | 231,485 | 152,268 | 147,732 | 156,810 | 162,311 | 162,755 | 164,145 | 165,389 | 161,345 | 166,034 |
| Change (%) | -34.22 | -2.98 | 6.14 | 3.51 | 0.27 | 0.85 | 0.76 | -2.45 | 2.91 | |
| % of Revenue | 32.34 | 39.97 | 37.05 | 35.55 | 37.76 | 38.35 | 38.63 | 40.14 | 39.84 | 42.32 |
| R&D | ||||||||||
| Change (%) | ||||||||||
| % of Revenue | ||||||||||
| OpEx | 684,135 | 355,912 | 365,508 | 409,357 | 405,569 | 401,906 | 398,545 | 394,556 | 392,396 | 388,786 |
| Change (%) | -47.98 | 2.70 | 12.00 | -0.93 | -0.90 | -0.84 | -1.00 | -0.55 | -0.92 | |
| % of Revenue | 95.58 | 93.44 | 91.67 | 92.80 | 94.34 | 94.71 | 93.80 | 95.75 | 96.88 | 99.11 |
| Operating Income | 31,666 | 25,005 | 33,226 | 31,780 | 24,318 | 22,454 | 26,344 | 17,514 | 12,635 | 3,503 |
| Change (%) | -21.04 | 32.88 | -4.35 | -23.48 | -7.66 | 17.32 | -33.52 | -27.86 | -72.27 | |
| % of Revenue | 4.42 | 6.56 | 8.33 | 7.20 | 5.66 | 5.29 | 6.20 | 4.25 | 3.12 | 0.89 |
| Interest Expense | -22,853 | -12,349 | -11,611 | -11,286 | -10,558 | -10,310 | -10,235 | -10,778 | -11,300 | -11,935 |
| Change (%) | -45.96 | -5.98 | -2.80 | -6.45 | -2.35 | -0.73 | 5.30 | 4.85 | 5.62 | |
| % of Revenue | -3.19 | -3.24 | -2.91 | -2.56 | -2.46 | -2.43 | -2.41 | -2.62 | -2.79 | -3.04 |
| Net Income | 4,628 | 8,125 | 16,578 | 15,338 | 10,092 | 8,813 | 11,934 | 5,015 | 671 | -8,433 |
| Change (%) | 75.56 | 104.02 | -7.48 | -34.20 | -12.67 | 35.41 | -57.98 | -86.61 | -1,355.94 | |
| % of Revenue | 0.65 | 2.13 | 4.16 | 3.48 | 2.35 | 2.08 | 2.81 | 1.22 | 0.17 | -2.15 |
Source: Capital IQ
